Privacy settings

Utilizziamo cookies tecnici, necessari per il corretto funzionamento del sito, cookies statistici e cookies di marketing (inclusi cookies di terze parti), al fine di mostrarti offerte e pubblicità basate sui tuoi gusti e preferenze. Per maggiori informazioni puoi consultare la nostra Privacy Policy. I cookies statistici e i cookies di marketing (inclusi cookies di terze parti) sono utilizzati esclusivamente con il tuo consenso. Cliccando “Seleziona tutto e acconsenti” consenti il trattamento dei cookies statistici e di marketing (inclusi cookies di terze parti).

Per personalizzare le tue impostazioni privacy, seleziona le tue preferenze tra le caselle qui sotto e clicca “Applica la selezione”. Ti ricordiamo per puoi modificare le tue impostazioni privacy in qualsiasi momento e disattivare i cookies, seguendo le istruzioni riportate nella Privacy Policy.

Show preferences Select all and accept
IMA is loading

2020 ISPE Europe Annual Conference • Madrid, Spain • 30 March – 2 April 2020

IMA Life is pleased to take part in the ISPE Europe Annual Conference focusing on Quality, Facility Design, Construction, Pharma 4.0 and Operational Excellence.

Post published on 17/02/2020

2020 ISPE Europe Annual Conference

IMA Life is pleased to take part in the ISPE Europe Annual Conference focusing on the roadmap to success: Quality, Facility Design, Construction, Pharma 4.0 and Operational Excellence.

Don’t miss the chance to join the event and meet our experts in aseptic processing at the booth #19.

For the first time, the 2020 ISPE Europe Annual Conference will introduce a Regulatory Panel as a plenary session. The panel will represent regulators from various countries and will address thought-provoking questions such as:

  • How will new product design change regulatory oversight? What is the impact of personalised medicine, small batches, small products, continuous manufacturing and extreme short shelf life products for example gene and cell therapy, on the classical principles of quality oversight by regulators and by manufacturers?
  • What are the up- and downsides of the harmonisation for pharmaceutical GMP rules between FDA, EMA, TGA, PIC/S and non-PIC/S members?
  • What is the role of pharmacopoeias in this context?

 

Meliá Avenida América
Calle de Juan Ignacio Luca de Tena Street, 36
Madrid, Spain

 

Register now»

Get in touch

For any further information,